What certifications should an acne patch factory have?

What certifications should an acne patch factory have?

Short answer: ISO 13485 covers how the factory is run and which product categories are in scope. FDA registration covers the facility and the product listing for the US market. CE marking for an acne patch is a Class I self-declaration, not a certificate issued by a notified body. They are three separate things, and a supplier who describes any one of them as "all the certification you need" is telling you something useful about how they work.

Three layers of evidence behind a patch supplier's certifications ISO 13485 covers the quality system and the product categories in scope. CE Class I is a self-declaration supported by a compliance report, not a notified-body certificate. The FDA FEI registers the building while the product needs its own device listing. A batch COA covers one lot only. Three layers of evidence, not one certificate A quality-system certificate, a market-access route and a batch record answer three different questions. Suppliers often quote one. SYSTEM ISO 13485:2016 · NQA 69136 Process controlled, categories in scope — to Jul 2028 MARKET CE — Class I declaration Self-declared. NQA report 03606, 93/42/EEC, to Mar 2027 MARKET FDA — FEI The building only. The product needs its own listing BATCH Batch COA This lot only. Nothing about the next one Ask for all three. A supplier who offers one as “all the certification you need” has told you how they work. Henso Biotech · ISO 13485:2016 (NQA 69136, scope includes Acne Patch) CE Class I · FDA-registered facility

Figure 1 — The three layers a supplier’s paperwork has to cover. One document cannot prove another.

ISO 13485 — the scope statement matters more than the certificate

ISO 13485:2016 certifies that the factory has documented processes for design control, supplier management, traceability, non-conforming product handling and corrective action. It does not certify any individual batch — a certified factory can still produce a failed lot. What the certificate gives a buyer is confidence that failures get caught and traced rather than shipped silently.

The part buyers should actually read is the scope statement, which lists the product categories covered. A certificate scoped only to wound dressings does not automatically cover cosmetic patches, and that distinction surfaces at customs. Ask for the scope page, not just the cover.

Henso's registration — Certificate No. 69136, ISO 13485:2016, issued by NQA (UKAS accredited, accreditation 015). Valid 06 July 2025 to 05 July 2028. The scope begins with Acne Patch and covers hydrocolloid blister plaster, hydrocolloid dressing, foam and silicone dressings, medical tapes and related wound care products.

The registration is verifiable on CNCA's public database (cnca.gov.cn) — quote the certificate number.

CE — Class I means self-declaration, and the wording matters

An acne patch is classified as a Class I medical device. Under the MDD Annex VII route, Class I devices do not require a notified body certificate — the manufacturer declares conformity themselves, and a compliance report from a third party reviews the technical file and test reports that support that declaration.

This is why the document is a compliance report rather than a certificate. The report itself states: "This report is not a certificate of conformity." A supplier who calls it a CE certificate is either misreading their own paperwork or hoping you will.

Henso's CE position — NQA Compliance Report No. 03606, product list explicitly including Acne Patch, classified Class I, assessed against Annex I and VII of 93/42/EEC. Initially issued 07 June 2019, renewed 18 March 2022, valid to 17 March 2027.

Accurate site wording: "CE marked as a Class I medical device" — not "CE certified by NQA".

FDA — two registrations, routinely conflated

For the US market there are two distinct steps, and suppliers usually mention only the first:

  • Establishment registration — the facility is registered with FDA and assigned a Facility Establishment Identifier (FEI). This concerns the building, not the product.
  • Device listing — each product is listed under that registration, with its classification.

"We are FDA registered" normally means the first. Necessary, but not sufficient: if the product is not listed, a shipment can still be held. Ask for the FEI number and the listing confirmation as two separate items.

Wording warning. "FDA registered facility" is accurate. "FDA approved" is not — and using it on packaging creates a compliance problem for whoever imports the goods, including you.

What each one proves

Document Proves Does not prove
ISO 13485 certificate The process is controlled, and these product categories are in scope That any specific batch passed
CE compliance report The technical file supports a Class I self-declaration That a notified body certified the product
FDA FEI The facility is known to FDA That your product is listed for import
Batch COA This specific lot met specification That the next lot will

One question worth asking in 2026

The EU Medical Device Regulation (2017/745) replaced the MDD in May 2021. A Class I device still self-declares under MDR, but the technical documentation has to meet MDR Annex II and III rather than the older MDD annexes.

So when you receive a compliance report citing 93/42/EEC, ask whether the technical file has been updated to MDR. For Class I devices this is usually a documentation exercise rather than a re-certification, but it is the difference between a smooth EU customs entry and a hold. Suppliers whose paperwork stops at MDD are not necessarily non-compliant — they may simply not have been asked.

The document set to request before a first order

  • ISO 13485 certificate including the scope page, with expiry date
  • CE declaration of conformity naming the regulation, plus the supporting compliance report
  • FDA FEI number and the product listing confirmation, separately
  • Material safety data sheet for the adhesive and the film
  • A batch certificate of analysis from a recent production run
  • Stability or shelf-life statement, with test conditions

Any of these that a supplier cannot produce within a few days is a signal worth weighing before you place a tooling order.

Henso Biotech — ISO 13485:2016 (NQA 69136, valid to 05 July 2028), CE Class I under MDD 93/42/EEC (NQA compliance report 03606, valid to 17 March 2027), FDA-registered facility. 11,500 m² plant in Zhongshan, 8 production lines, 28.8 million patches per month.

Send your destination market and product type, and we will confirm which route applies before you commit to packaging.